Does OBINUTUZUMAB Cause Infusion related reaction? 789 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 789 reports of Infusion related reaction have been filed in association with OBINUTUZUMAB (Gazyva). This represents 5.6% of all adverse event reports for OBINUTUZUMAB.
789
Reports of Infusion related reaction with OBINUTUZUMAB
5.6%
of all OBINUTUZUMAB reports
58
Deaths
252
Hospitalizations
How Dangerous Is Infusion related reaction From OBINUTUZUMAB?
Of the 789 reports, 58 (7.4%) resulted in death, 252 (31.9%) required hospitalization, and 48 (6.1%) were considered life-threatening.
Is Infusion related reaction Listed in the Official Label?
Yes, Infusion related reaction is listed as a known adverse reaction in the official FDA drug label for OBINUTUZUMAB.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Pneumonia (662)
Anaemia (640)
Atrial fibrillation (548)
What Other Drugs Cause Infusion related reaction?
INFLIXIMAB (12,946)
RITUXIMAB (11,871)
TOCILIZUMAB (8,340)
METHOTREXATE (7,225)
ADALIMUMAB (6,865)
ABATACEPT (6,759)
PREDNISONE (6,481)
LEFLUNOMIDE (6,205)
HYDROXYCHLOROQUINE (5,991)
ETANERCEPT (5,960)
Which OBINUTUZUMAB Alternatives Have Lower Infusion related reaction Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE